Found 11 matching trials
89Zr-Bevacizumab PET/CT Imaging in NF2 Patients
N/ABevacizumab can be an effective treatment for individuals with NF2 and impr...
Location
Leiden University Medical Center
Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron Emission Tomography (PET)
N/AInhibition of Heat Shock Protein (HSP)90 is a new, promising treatment moda...
Location
University Medical Center Groningen
VEGF Imaging in Renal Cell Carcinoma
N/AThe primary objective of the study is to evaluate the feasibility of 89Zr-b...
Location
University Medical Center Groningen
Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma
N/AEverolimus indirectly inhibits angiogenesis by reducing VEGF production. VE...
Location
University Medical Centre Groningen
89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors
N/AThis is a pilot study for evaluation of 89Zr-bevacizumab PET imaging as pre...
Location
University Medical Center Groningen
VEGF Early Imaging for Breast Cancer
EARLY_PHASE1Breast cancer is the most common cause of cancer death among women. Yearly ...
Location
Universitar Medical Center Groningen
Angiogenic Imaging in Pulmonary Arterial Hypertension
PHASE1Pulmonary arterial hypertension (PAH) is a disorder of elevated pulmonary v...
Location
Brigham and Women's Hospital
Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease
N/AVon Hippel Lindau disease (VHLD) is an inherited syndrome characterized by ...
Location
University Medical Center Groningen
89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple Myeloma
NAThe purpose of this study is to see whether 89Zr-bevacizumab PET scanning i...
89Zr-RO5323441 PET Imaging in Glioblastoma
PHASE2The research the investigators propose is a molecular imaging study of RO53...
Location
University Medical Center Groningen